- Home
- THQ vs CRON Comparison
THQ vs CRON Comparison
Compare THQ & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THQ
- CRON
- Stock Information
- Founded
- THQ 2014
- CRON N/A
- Country
- THQ United States
- CRON Canada
- Employees
- THQ N/A
- CRON N/A
- Industry
- THQ Finance Companies
- CRON Medicinal Chemicals and Botanical Products
- Sector
- THQ Finance
- CRON Health Care
- Exchange
- THQ Nasdaq
- CRON Nasdaq
- Market Cap
- THQ 782.9M
- CRON 684.7M
- IPO Year
- THQ N/A
- CRON N/A
- Fundamental
- Price
- THQ $18.33
- CRON $1.92
- Analyst Decision
- THQ
- CRON
- Analyst Count
- THQ 0
- CRON 0
- Target Price
- THQ N/A
- CRON N/A
- AVG Volume (30 Days)
- THQ 158.9K
- CRON 2.0M
- Earning Date
- THQ 01-01-0001
- CRON 05-08-2025
- Dividend Yield
- THQ 7.53%
- CRON N/A
- EPS Growth
- THQ N/A
- CRON N/A
- EPS
- THQ N/A
- CRON 0.13
- Revenue
- THQ N/A
- CRON $124,589,000.00
- Revenue This Year
- THQ N/A
- CRON $25.49
- Revenue Next Year
- THQ N/A
- CRON $7.45
- P/E Ratio
- THQ N/A
- CRON $15.47
- Revenue Growth
- THQ N/A
- CRON 33.92
- 52 Week Low
- THQ $15.29
- CRON $1.60
- 52 Week High
- THQ $20.38
- CRON $2.64
- Technical
- Relative Strength Index (RSI)
- THQ 47.94
- CRON 44.96
- Support Level
- THQ $17.82
- CRON $1.98
- Resistance Level
- THQ $18.73
- CRON $2.07
- Average True Range (ATR)
- THQ 0.34
- CRON 0.07
- MACD
- THQ 0.05
- CRON -0.02
- Stochastic Oscillator
- THQ 55.86
- CRON 4.17
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.